Business Context and Reporting Period
This Form 8-K is a current report filed by Predictive Oncology Inc. (ticker: POAI) on September 19, 2025. The filing details the results of a Special Meeting of Stockholders held on the same date and the subsequent approval of a reverse stock split. Note: The request metadata lists "Axe Compute Inc.," but the filing text explicitly identifies the registrant as Predictive Oncology Inc.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
- Reverse Stock Split: Stockholders approved a one-for-fifteen (1:15) reverse stock split of the Company's common stock. The split is effective as of 5:00 PM ET on September 29, 2025, with trading on a reverse-split-adjusted basis expected to begin on September 30, 2025.
- Share Count Adjustment: Every 15 shares of issued and outstanding common stock will be combined into one share. Fractional shares will be rounded up to the next whole number.
- Securities Identification: The new CUSIP number for the common stock is 74039M408.
- Capital Authorization: The reverse split does not change the total number of authorized shares of common or preferred stock.
Guidance, Outlook, and Voting Results
The filing reports the results of three proposals submitted to stockholders at the Special Meeting. As of the record date (August 18, 2025), there were 10,892,657 shares outstanding.
| Proposal | Voted For | Voted Against | Abstentions | Broker Non-Votes | Outcome |
|---|---|---|---|---|---|
| 1. Reverse Stock Split (1:15) | 3,739,479 | 1,317,568 | 54,693 | 1 | Approved |
| 2. Standby Equity Purchase Agreement (up to $10M) | 1,301,709 | 355,445 | 88,591 | 3,365,996 | Approved |
| 3. Adjournment of Meeting | 3,850,719 | 1,146,863 | 114,155 | 4 | Approved (Not Required) |
Management Commentary: Although the Adjournment Proposal was approved, no adjournment was necessary because a quorum was present and the primary proposals were approved. A press release regarding the reverse stock split was issued on September 25, 2025.
Investor Verification Checklist
- Verify the new CUSIP number (74039M408) for the common stock.
- Confirm the effective time of the reverse split (September 29, 2025, 5:00 PM ET) and the first day of adjusted trading (September 30, 2025).
- Review the Standby Equity Purchase Agreement details to understand the $10,000,000 issuance authorization.
- Check the Company's subsequent filings for updated share counts post-split.